Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 4.5 microgram/ml (equivalent: adrenaline (epinephrine), qty 2.5 microgram/ml); bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia; epidural block for surgery, field block (minor and major nerve blocks and infiltration). analgesia; continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. field block (minor nerve block and infiltration). the choice of 4 strengths, 0.125%, 0.25%, 0.375% and 0.5%, makes it possible to vary the degree of motor blockade.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - adrenaline acid tartrate 1.8mg equivalent to 1:1000 or 1 mg/ml adrenaline - solution for injection - 1:1000 - active: adrenaline acid tartrate 1.8mg equivalent to 1:1000 or 1 mg/ml adrenaline excipient: sodium chloride sodium metabisulfite water for injection - for the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10ml adrenaline - solution for injection - 1:10000 - active: adrenaline acid tartrate 1.8mg equivalent to 1:10000 or 1 mg/10ml adrenaline excipient: sodium chloride sodium metabisulfite water for injection - for the treatment of acute allergic reactions, life-threatening angioneurotic oedema, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline 1 mg/ml;   - solution for injection - 1 mg/ml - active: adrenaline 1 mg/ml   excipient: sodium chloride sodium metabisulfite tartaric acid water for injection - latest regulatory activity

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:100000; lidocaine hydrochloride 2%;   - solution for injection - 1:100000/2% in 2.2ml - active: adrenaline acid tartrate 1:100000 lidocaine hydrochloride 2%  

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.375%;   - solution for injection - 1:200000/0.375% - active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.375%   excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 1:200000;  ; bupivacaine hydrochloride monohydrate 0.5%; adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.5% - solution for injection - 1:200000/0.5% - active: adrenaline acid tartrate 1:200000   bupivacaine hydrochloride monohydrate 0.5% excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.5% excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.75%;   - solution for injection - 1:200000/0.75% - active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.75%  

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 1:400000;  ; bupivacaine hydrochloride monohydrate 0.25%; adrenaline acid tartrate 1:400000; bupivacaine hydrochloride monohydrate 0.25% - solution for injection - 1:400000/0.25% - active: adrenaline acid tartrate 1:400000   bupivacaine hydrochloride monohydrate 0.25% excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 1:400000 bupivacaine hydrochloride monohydrate 0.25% excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration).

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline;  ; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous; adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline; lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline   lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection active: adrenaline acid tartrate 0.018mg equivalent to 10 µg adrenaline lidocaine hydrochloride monohydrate 10.7mg equivalent to 10 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid as 2m solution for ph adjustment nitrogen as nitrogen for injection sodium chloride sodium hydroxide as 2m solution for ph adjustment sodium metabisulfite water for injection